These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7689276)

  • 1. FK 506 treatment of intractable rejection after liver transplantation.
    Jost U; Winkler M; Ringe B; Rodeck B; Pichlmayr R
    Transplant Proc; 1993 Aug; 25(4):2686-7. PubMed ID: 7689276
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):679-88. PubMed ID: 7679840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
    Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
    Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
    Woodle ES; So S; Jendrisak MD; Perdrizet GA; White HM; Marsh JW
    Transplant Proc; 1993 Apr; 25(2):1988-9. PubMed ID: 7682358
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of FK 506 for treatment of chronic rejection after liver transplantation.
    Winkler M; Ringe B; Gerstenkorn C; Rodeck B; Gubernatis G; Wonigeit K; Pichlmayr R
    Transplant Proc; 1991 Dec; 23(6):2984-6. PubMed ID: 1721334
    [No Abstract]   [Full Text] [Related]  

  • 6. FK 506 rescue therapy: early conversion improves efficacy.
    Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
    Transplant Proc; 1993 Apr; 25(2):1990-1. PubMed ID: 7682359
    [No Abstract]   [Full Text] [Related]  

  • 7. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
    Sher LS; Cosenza CA; Petrovic LM; Rojter S; Hoffman A; Lopez RR; Meehan M; Pan SH; Vierling J; Makowka L
    Transplant Proc; 1996 Apr; 28(2):1011-3. PubMed ID: 8623212
    [No Abstract]   [Full Text] [Related]  

  • 8. Conversion to rescue therapy with FK 506: data from eight liver transplant patients.
    Reggiani P; Orsenigo R; Gatti S; Albani AP; Ferla G; Doglia M; Fassati LR; Galmarini D
    Transplant Proc; 1994 Dec; 26(6):3597-8. PubMed ID: 7527982
    [No Abstract]   [Full Text] [Related]  

  • 9. FK 506 as treatment of late acute rejection in liver transplant patients.
    Rucay P; Samuel D; Farges O; Reynes M; Bismuth H
    Transplant Proc; 1995 Feb; 27(1):1105-6. PubMed ID: 7533354
    [No Abstract]   [Full Text] [Related]  

  • 10. High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study.
    Cherqui D; Duvoux C; Salvat A; Lauzet JY; Metreau JM; Julien M; Fagniez PL; Dhumeaux D
    Transplant Proc; 1995 Feb; 27(1):1134-5. PubMed ID: 7878824
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):641-3. PubMed ID: 7679828
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group.
    Abouljoud MS; Levy MF; Klintmalm GB
    Transplant Proc; 1995 Feb; 27(1):1121-3. PubMed ID: 7533360
    [No Abstract]   [Full Text] [Related]  

  • 13. OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection.
    Platz KP; Mueller AR; Zytowski M; Bechstein WO; Blumhardt G; Lobeck H; Neuhaus P
    Transplant Proc; 1995 Feb; 27(1):1111-3. PubMed ID: 7533357
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma level-guided low-dose FK 506 therapy in patients with early liver dysfunction after liver transplantation.
    Winkler M; Ringe B; Jost U; Gubernatis G; Pichlmayr R
    Transplant Proc; 1993 Aug; 25(4):2688-90. PubMed ID: 7689277
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful use of tacrolimus for initial rejection episodes after liver transplantation.
    Millis JM; Cronin DC; Newell KA; Bruce DS; Woodle ES; Grewal HP; Loss GE; Lissoos T; Conjeevaram H; Schiano T; O'Laughlin R; Charette J; McNaughton M; Baker AL; Thistlethwaite JR
    Transplant Proc; 1998 Jun; 30(4):1407-8. PubMed ID: 9636569
    [No Abstract]   [Full Text] [Related]  

  • 16. FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients.
    Shaw BW; Markin R; Stratta R; Langnas A; Donovan J; Sorrell M
    Transplant Proc; 1991 Dec; 23(6):2994-5. PubMed ID: 1721338
    [No Abstract]   [Full Text] [Related]  

  • 17. Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection.
    Wiesner RH; Porayko MK; Wahlstrom HE; Gores GJ; Kamath PS; Hay JE; Krom RA
    Transplant Proc; 1993 Apr; 25(2):1791-3. PubMed ID: 7682352
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of elevated FK 506 plasma levels with nephrotoxicity in liver-grafted patients.
    Winkler M; Jost U; Ringe B; Gubernatis G; Wonigeit K; Pichlmayr R
    Transplant Proc; 1991 Dec; 23(6):3153-5. PubMed ID: 1721389
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
    Platz KP; Tullius SG; Mueller AR; Schumacher G; Nüssler N; Neuhaus R; Bechstein WO; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235
    [No Abstract]   [Full Text] [Related]  

  • 20. FK 506 used as rescue therapy for refractory liver allograft rejection.
    Chen CL; Eng HL; Chen YS; Kuo YC; Sun CK
    Transplant Proc; 1994 Aug; 26(4):1927-9. PubMed ID: 7520612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.